Mallory body-A disease-associated type of sequestosome

Kopito, 2000, Aggresomes, inclusion bodies and protein aggregation, Trends Cell Biol, 10, 524, 10.1016/S0962-8924(00)01852-3 Wickner, 1999, Posttranslational quality control: folding, refolding, and degrading proteins, Science, 286, 1888, 10.1126/science.286.5446.1888 Hartl, 1996, Molecular chaperones in cellular protein folding, Nature, 381, 571, 10.1038/381571a0 Johnston, 1998, Aggresomes: a cellular response to misfolded proteins, J Cell Biol, 143, 1883, 10.1083/jcb.143.7.1883 Bukan, 2000, Getting newly synthesized proteins into shape, Cell, 101, 119, 10.1016/S0092-8674(00)80806-5 Hirsch, 2000, Intracellular targeting of the proteasome, Trends Cell Biol, 10, 268, 10.1016/S0962-8924(00)01768-2 Glickman, 2000, Getting in and out of the proteasome, Cell Dev Biol, 11, 149 Wilkinson, 2000, Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome, Cell Dev Biol, 11, 141 Grune, 1997, Degradation of oxidized proteins in mammalian cells, FASEB J, 11, 526, 10.1096/fasebj.11.7.9212076 Shin, 1998, P62 and the sequestosome, a novel mechanism for protein metabolism, Arch Pharm Res, 21, 629, 10.1007/BF02976748 Vadlamudi, 1998, Genomic structure and promoter analysis of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein, FEBS Lett, 435, 138, 10.1016/S0014-5793(98)01021-7 Lee, 1998, Immediate early response of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein, FEBS Lett, 438, 297, 10.1016/S0014-5793(98)01323-4 Ishii, 1996, Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56lck-associated protein in response to oxidative stress, Biochem Biophys Res Commun, 226, 456, 10.1006/bbrc.1996.1377 Ishii, 1997, Low micromolar levels of hydrogen peroxide and proteasome inhibitors induce the 60-kDa A170 stress protein in murine peritoneal macrophages, Biochem Biophys Res Commun, 232, 33, 10.1006/bbrc.1997.6221 Ishii, 1999, Oxidative stress-inducible proteins in macrophages, Free Radical Res, 31, 351, 10.1080/10715769900300921 Yanagawa, 1997, Phosphorylation of a 170 stress protein by casein kinase II-like activity in macrophages, Biochem Biophys Res Commun, 241, 157, 10.1006/bbrc.1997.7783 Joung, 1996, Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH domain, Proc Natl Acad Sci U S A, 93, 5991, 10.1073/pnas.93.12.5991 Rachubinski, 1999, The p56lck-interacting protein p62 stimulates transcription via the SV40 enhancer, J Biol Chem, 274, 18278, 10.1074/jbc.274.26.18278 Puls, 1997, Interaction of protein kinase C ζ with ZIP, a novel protein kinase C-binding protein, Proc Natl Acad Sci U S A, 94, 6191, 10.1073/pnas.94.12.6191 Sanchez, 1998, Localization of atypical protein kinase C isoforms into lysosome targeted endosomes through interaction with p62, Mol Cell Biol, 18, 3069, 10.1128/MCB.18.5.3069 Sanz, 1999, The interaction of p62 with RIP links the atypical PKCs to NF-κB activation, EMBO J, 18, 3044, 10.1093/emboj/18.11.3044 Okazaki, 1999, Cloning, expression profile, and genomic organization of the mouse STAP/A/70 gene, Genomics, 60, 87, 10.1006/geno.1999.5902 Moscat, 2000, The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters, EMBO Reports, 1, 399, 10.1093/embo-reports/kvd098 Sanz, 2000, The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAFG pathway, EMBO J, 19, 1576, 10.1093/emboj/19.7.1576 Sudo, 2000, p62 functions as a p38 MAP kinase regulator, Biochem Biophys Res Commun, 269, 521, 10.1006/bbrc.2000.2333 Diaz-Meco, 2001, MEKS, a new target of the atypical protein kinase C isoforms in mitogenic signaling, Mol Cell Biol, 21, 1218, 10.1128/MCB.21.4.1218-1227.2001 Wooten, 2001, The atypical protein kinase C-interacting protein p62 is a scaffold for NF-κB activation by nerve growth factor, J Biol Chem, 276, 7709, 10.1074/jbc.C000869200 Denk, 2000, Mallory body revisited, J Hepatol, 32, 689, 10.1016/S0168-8278(00)80233-0 Zatloukal, 2002, P62 is a common component of cytoplasmic inclusions in protein aggregation diseases, Am J Pathol, 160, 255, 10.1016/S0002-9440(10)64369-6 Stumptner, 2001, Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation, J Hepatol, 34, 665, 10.1016/S0168-8278(00)00099-4 Zatloukal, 2000, Cytokeratin 8 protects from hepatotoxicity and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies, Am J Pathol, 156, 1263, 10.1016/S0002-9440(10)64997-8 Stumptner, 2000, Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a Mallory body mouse model, Am J Pathol, 156, 77, 10.1016/S0002-9440(10)64708-6 Stumptner, 1999, Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma: demonstration of p62 as a major constituent, Am J Pathol, 154, 1701, 10.1016/S0002-9440(10)65426-0 Zatloukal, 1990, Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin treated mouse, Hepatology, 11, 652, 10.1002/hep.1840110419 Preisegger, 1992, Common epitopes of human and murine Mallory bodies and Lewy bodies as revealed by a neurofilament antibody, Lab Invest, 66, 193 Ku, 2000, Keratins turn over by ubiquitination in a phosphorylation-modulated fashion, J Cell Biol, 149, 547, 10.1083/jcb.149.3.547 Magin, 1998, Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates, J Cell Biol, 140, 1441, 10.1083/jcb.140.6.1441 Lieber, 2000, Alcoholic liver disease: new insights in pathogenesis lead to new treatments, J Hepatol, 32, 113, 10.1016/S0168-8278(00)80420-1 Yuan, 2000, Dexamethasone enhances Mallory body formation in drug-primed mouse liver, Exp Mol Pathol, 69, 202, 10.1006/exmp.2000.2320 Taub, 1998, Blocking NF-κB in the liver: the good and bad news, Hepatology, 27, 1445, 10.1002/hep.510270538 Miyoshi, 2001, NF-κB is activated in cholestasis and functions to reduce liver injury, Am J Pathol, 158, 967, 10.1016/S0002-9440(10)64043-6 Lowe, 1988, Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease, J Pathol, 155, 9, 10.1002/path.1711550105 Fataccioli, 1998, Effects of chronic ethanol administration on rat liver proteasome activities; relationship with oxidative stress, Hepatology, 29, 14, 10.1002/hep.510290106 Bardag-Gorce, 2001, Mallory bodies formed in proteasome-depleted hepatocytes: an immunohistochemical study, Exp Mol Pathol, 70, 7, 10.1006/exmp.2000.2343 Bence, 2001, Impairment of the ubiquitin-proteasome system by protein aggregation, Science, 292, 1552, 10.1126/science.292.5521.1552